These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8137608)

  • 1. Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.
    Welch LP; Leader WG; Chandler MH
    Clin Pharm; 1993 Dec; 12(12):909-13. PubMed ID: 8137608
    [No Abstract]   [Full Text] [Related]  

  • 2. Gentamicin, tobramycin and netilmicin pharmacokinetics in plasma and pleural fluid.
    Limthongkul S; Poshyachinda M; Charoenlap P; Nuchprayoon C
    J Med Assoc Thai; 1988 Oct; 71(10):541-7. PubMed ID: 3249161
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
    Tointon MM; Job ML; Peltier TT; Murphy JE; Ward ES
    Clin Pharm; 1987 Feb; 6(2):160-2. PubMed ID: 3665369
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in aminoglycoside pharmacokinetics in patients with cancer.
    Higa GM; Murray WE
    Clin Pharm; 1987 Dec; 6(12):963-6. PubMed ID: 3427879
    [No Abstract]   [Full Text] [Related]  

  • 6. More on variability in aminoglycoside volume of distribution.
    Dasta JF; Armstrong DK
    Clin Pharm; 1987 Mar; 6(3):193. PubMed ID: 3665376
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of serum aminoglycoside concentrations produced by two infusion methods.
    Bosch DE; Williams DN
    Clin Pharm; 1990 Oct; 9(10):777-80. PubMed ID: 2242658
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
    De Cock RF; Allegaert K; Brussee JM; Sherwin CM; Mulla H; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Pharm Res; 2014 Oct; 31(10):2643-54. PubMed ID: 24789450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting aminoglycoside dosage in critically ill patients with sepsis.
    Stevens MR
    Clin Pharm; 1987 Apr; 6(4):272-3. PubMed ID: 3665382
    [No Abstract]   [Full Text] [Related]  

  • 10. Some questions of aminoglycoside therapy in the intensive care unit.
    Csapó K; Faragó E
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):432-5. PubMed ID: 3198296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients.
    Reed RL; Wu AH; Miller-Crotchett P; Crotchett J; Fischer RP
    J Trauma; 1989 Nov; 29(11):1462-8; discussion 1468-70. PubMed ID: 2585556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.
    Zantvoort FA; Wagenvoort JH; Derkx FH; Michel MF
    Br J Clin Pharmacol; 1987 Oct; 24(4):511-8. PubMed ID: 3689631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies.
    Fernández de Gatta MM; Fruns I; Hernández JM; Caballero D; San Miguel JF; Martínez Lanao J; Domínguez-Gil Hurlé A
    Clin Pharm; 1993 Jul; 12(7):515-20. PubMed ID: 8354038
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tobramycin on the renal handling of vancomycin.
    Munar MY; Elzinga L; Brummett R; Golper TA; Bennett WM
    J Clin Pharmacol; 1991 Jul; 31(7):618-23. PubMed ID: 1894757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body weight on aminoglycoside pharmacokinetics in patients with hypoalbuminemia.
    Kale-Pradhan PB; Buckler V; Bush PW
    Am J Health Syst Pharm; 1997 Oct; 54(19):2201-3. PubMed ID: 9331441
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement.
    González Della Valle A; Bostrom M; Brause B; Harney C; Salvati EA
    Acta Orthop Scand; 2001 Jun; 72(3):237-40. PubMed ID: 11480597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.